CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant RejectionBusiness Wire • 07/18/25
CareDx: The Transplant Diagnostics Leader, But Challenges Will Increase On The Road AheadSeeking Alpha • 06/14/25
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. ShareholdersBusiness Wire • 05/22/25
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation MeetingBusiness Wire • 04/29/25
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation MeetingBusiness Wire • 04/24/25
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNABusiness Wire • 03/28/25
CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNAPRNewsWire • 03/15/25
CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/27/25
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million VerdictBusiness Wire • 02/25/25
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant PatientsBusiness Wire • 02/20/25
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic MalignanciesBusiness Wire • 02/13/25
Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect?Zacks Investment Research • 02/05/25